Sponsors
Meet Our Event Sponsors
Our line-up of visionary companies ready to connect with you, offering leading technologies and solutions to advance your cell & gene research.
![Sponsor Circle Image Sponsor Circle Image](https://oxfordglobal.com/hs-fs/hubfs/Sponsor%20Circle%20Image.png?width=400&height=400&name=Sponsor%20Circle%20Image.png)
Cell 2024
Gold Sponsors
Silver Sponsors
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/89e73045-dbe1-45fb-be21-b8d81b312e3e-2-5668375logo-1.GenScriptCorporation_Logo_EN_Horizontal_FullColor.png?length=600&name=89e73045-dbe1-45fb-be21-b8d81b312e3e-2-5668375logo-1.GenScriptCorporation_Logo_EN_Horizontal_FullColor.png)
GenScript Biotech Corporation is a world leading technology and service provider of life science R&D and manufacturing, founded in 2002 as one of the first commercialise gene synthesis providers. GenScript provides life sciences services and products to scientists in over 200 countries worldwide, including gene and gene fragments synthesis, DNA/RNA/NGS/qPRC/tRNA, & siRNA oligos, mRNA & circular RNA synthesis, custom peptide synthesis, complex protein expression and engineering, custom antibody development and engineering, in vitro/in vivo pharmacology, as well as a variety of other research-focused catalogue products. After two decades of rapid growth, the company has expanded its business in recent years into the fields of immunotherapy and early-phase drug discovery services, CDMO and microbiology. Driven by the corporate mission of “make people and nature healthier through biotechnology”, GenScript strives to become the most trustworthy biotech company in the world. GenScript offers global support for its loyal customers with dedicated sites in the Netherlands and the UK and a strong global remote workforce.
Bronze Sponsors
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/4d007ff2-1862-4abd-843a-92e24906adb0-2-5668375logo-aseptic_technologies_Logo_Blue_RGB.png?length=600&name=4d007ff2-1862-4abd-843a-92e24906adb0-2-5668375logo-aseptic_technologies_Logo_Blue_RGB.png)
Aseptic Technologies manufactures fill & finish equipment and devices for advanced pharmaceutical manufacturing. Our core expertise lays in the innovation of aseptic filling processes for biopharmaceutical products, including cell and gene therapy products. The AT-Closed Vial® Technology is an innovative vial, closed before filling, made out of polymer materials. Together with our Filling Lines, the technology allows for contamination risk reduction and higher levels of sterility. In addition, its exceptional features make the AT-Closed Vial® able to maintain Container Closure Integrity (CCI) at cryogenic temperatures (down to -196°C). As a member of SKAN Group, we leverage the technological excellence of SKAN in the isolator design, providing integrated solutions for fill & finish projects, globally. Furthermore, we share decades of expertise in injection molding and manufacturing in cleanroom, offering customized ready-to-use assemblies for pharmaceutical processes. www.aseptictech.com www.skan.com
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/55b8d348-c564-4ef9-ba33-f793f95a3c62-2-5668375logo-bm-logo-circle-rgb-(1).png?length=600&name=55b8d348-c564-4ef9-ba33-f793f95a3c62-2-5668375logo-bm-logo-circle-rgb-(1).png)
To protect patients, provide safe products and minimise vein to vein time, cellular therapies sites need state-of-the-art quality control solutions. bioMérieux’s portfolio of microbiology testing solutions enable sites to perform testing at each stage of production. bioMérieux solutions are adapted for the unique set of requirements for testing C> products. Helping to maintain regulatory compliance and optimise operations for the future. BACT/ALERT 3D DUAL T: Compendial, rapid and automated sterility testing. BIOFIRE MYCOPLASMA: Results in 1 hour test ENDOZYME II GO: LAL-free endotoxin test, just add water and your sample 3P Solutions: for environmental monitoring, 3P SMART plates, 3P Connect and 3P Enterprise bioMérieux industrial microbiology (biomerieux-industry.com)
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/afea1704-eb4a-4eb5-9f95-e9e63ceda3af-2-5668375logo-Eppendorf-logo-RGB-white-background.png?length=600&name=afea1704-eb4a-4eb5-9f95-e9e63ceda3af-2-5668375logo-Eppendorf-logo-RGB-white-background.png)
We Help Bring Life-Saving Treatments to the World Large cell numbers are needed for the development of cell therapies and stem cell-based drug research applications. By utilizing its strong synergies in cell culture expertise, bioreactor technology, and polymer manufacturing, Eppendorf has emerged as an expert partner for the cultivation of (stem-) cells at large scale. With our equipment, training programs, and application services, we support scientists in resolving cultivation bottlenecks during the development of cell-based applications from basic research to cell and gene therapy applications. The need for advanced solutions is increasing. With our expertise, we help to stimulate the growth of your cultures and cultivate solutions tailored to your challenges. Since 1945, the Eppendorf brand has been synonymous with customer-oriented processes and innovative products, such as laboratory devices and consumables for liquid handling, cell handling and sample handling. Today, Eppendorf and its more than 5,000 employees serve as experts and advisors, using their unique knowledge and experience to support laboratories and research institutions around the world.
Innovation for a Better World Discover our pioneering process sensor technology at Hamilton Process Analytics. We are dedicated to enhancing the understanding and control of Critical Process Parameters and process Key Performance Indicators to solve bioprocess challenges. Designed for bioprocesses in biopharma and other industries, our in-line process analytics sensor solutions offer real-time measurement of critical process parameters and key performance indicators.
Network & Programme Sponsors
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/879b2da8-e0f2-4f5f-9d63-b64a5f472408-2-5668375logo-AirProducts-logo-GREEN-347-PNG.png?length=600&name=879b2da8-e0f2-4f5f-9d63-b64a5f472408-2-5668375logo-AirProducts-logo-GREEN-347-PNG.png)
Air Products (NYSE:APD) is a world-leading industrial gases company in operation for over 80 years focused on serving energy, environmental, and emerging markets. The Company has two growth pillars driven by sustainability. Air Products’ base business provides essential industrial gases, related equipment and applications expertise to customers in dozens of industries, including refining, chemicals, metals, electronics, manufacturing, and food. The Company also develops, engineers, builds, owns and operates some of the world's largest clean hydrogen projects supporting the transition to low- and zero-carbon energy in the heavy-duty transportation and industrial sectors. Additionally, Air Products is the world leader in the supply of liquefied natural gas process technology and equipment, and provides turbomachinery, membrane systems and cryogenic containers globally. The Company had fiscal 2023 sales of $12.6 billion from operations in approximately 50 countries and has a current market capitalisation of about $50 billion. Approximately 23,000 passionate, talented and committed employees from diverse backgrounds are driven by Air Products’ higher purpose to create innovative solutions that benefit the environment, enhance sustainability and reimagine what's possible to address the challenges facing customers, communities, and the world. For more information, visit www.airproducts.co.uk or follow us on LinkedIn, X, Facebook or Instagram.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/db73a9eb-f836-46f3-86e9-196ac7a5db65-2-5668375logo-PathoQuest-logo-big-V2.jpg?length=600&name=db73a9eb-f836-46f3-86e9-196ac7a5db65-2-5668375logo-PathoQuest-logo-big-V2.jpg)
PathoQuest is a global CRO that specializes in biologics GMP quality testing based on next-generation sequencing (NGS) for viral safety and genetic characterization. The company’s proprietary NGS-based testing approach delivers actionable Quality Control reports to the biopharmaceutical industry for cell & gene therapy, vaccines and recombinants. Faster, safer, Animal Free.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/1f423897-85bd-4efa-a3f0-344d172c2f82-2-5668375logo-Logo.jpg?length=600&name=1f423897-85bd-4efa-a3f0-344d172c2f82-2-5668375logo-Logo.jpg)
SSG Vitrology Limited was founded in 2007 and acquired by SGS in May 2012. The site provides safety testing services of biologics, with a strong focus on quality of service and scientific ability. Our team of experienced scientists have over 20+ years experience providing a comprehensive range of GMP, FDA, EP, ICH compliant validated assays. As a world leader in biopharmaceutical testing services, SGS Vitrology offer you a complete range of GLP/GMP biologics safety testing, including virology, cellular and molecular biology, as well as microbiology and electron microscopy. We pay special attention to our customers’ turnaround time requirements and partner that with best in class customer service and communication. As a result, we help you to ensure product safety and meet your regulatory requirements, therefore adding value to your business by providing reliability, high quality & compliant GMP validated assays, scientific expertise, and pro-active communication with direct access to your dedicated project management team and scientists. SGS Vitrology has decades of experience characterizing cell banks and virus seeds used in the manufacture of gene therapy vectors, vaccines, and recombinant proteins. We have worked with clients using a range of cell lines (e.g. CHO, HEK293, Sp2/0, Hi5, Sf9, MDCK, Hybridoma) and viral vectors (e.g. Adeno, AAV, Lentivirus, Vaccinia). A summary of our services are as follows: • Cell Bank and Virus Seed Characterisation per the major compendia, regulatory and ICH guidelines • Raw material and Bulk Harvest testing • Drug Substance and Final Product testing • Custom Development/Validation of assays including new or method transfers
Our extensive and engaged community extends across large, mid-size and innovative start-ups within the pharma and biotech space, with a dedicated audience spanning a range of specialisms. Whether you have content to share, are looking for ways to enhance your brand visibility or would like to increase engagement with prospective customers, Oxford Global can offer valuable access to your target demographic through our range of event & content services.
-
At Oxford Global, our events are designed to connect key life science figures and innovative solution providers, accelerating scientific advancement. Our goal is to create valuable connections and an impactful experience through innovative and collaborative formats.
-
Digital Marketing Services
Oxford Global’s products offer a powerful channel to associate your brand with the latest advancements within the industry whilst educating and influencing the industry throughout their buying process.